We are live on ! Find out more
SCMP

Sucampo Pharmaceuticals, Inc.
SCMP

Delisted

SCMP was delisted on the 12th of February, 2018.

167 hedge funds and large institutions have $272M invested in Sucampo Pharmaceuticals, Inc. in 2017 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 68 increasing their positions, 46 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

170% more call options, than puts

Call options by funds: $1.97M | Put options by funds: $730K

48% more repeat investments, than reductions

Existing positions increased: 68 | Existing positions reduced: 46

0% more funds holding

Funds holding: 167167 (0)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 23

5% less capital invested

Capital invested by funds: $287M → $272M (-$14.9M)

Holders
167
Holders Change
Holders Change %
0%
% of All Funds
4.16%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
23
Increased
68
Reduced
46
Closed
23
Calls
$1.97M
Puts
$730K
Net Calls
+$1.24M
Net Calls Change
+$883K
Name Holding Trade Value Shares
Change
Change in
Stake
ACM
26
Ativo Capital Management
Illinois
$1.45M +$296K +29,009 +27%
BPM
27
Bowling Portfolio Management
Ohio
$1.42M +$884K +86,750 +180%
Ameriprise
28
Ameriprise
Minnesota
$1.38M +$17.2K +1,690 +1%
Cerity Partners
29
Cerity Partners
New York
$1.31M +$96K +9,416 New
MERSOM
30
Municipal Employees' Retirement System of Michigan
Michigan
$1.27M +$1.17M +114,970 +2,038%
PAM
31
Panagora Asset Management
Massachusetts
$1.26M +$1.21M +118,489 +7,816%
QI
32
QS Investors
New York
$1.22M
Goldman Sachs
33
Goldman Sachs
New York
$1.22M -$716K -70,254 -38%
MC
34
Menta Capital
California
$1.2M -$260K -25,515 -18%
Bank of America
35
Bank of America
North Carolina
$1.18M +$231K +22,613 +25%
HHC
36
Hutchin Hill Capital
New York
$1.17M +$1.14M +111,500 New
GC
37
Globeflex Capital
California
$1.09M
MWNA
38
Marshall Wace North America
New York
$1.06M +$984K +96,540 New
BGIM
39
Brandywine Global Investment Management
Pennsylvania
$1.05M -$205K -20,102 -17%
AA
40
AlphaMark Advisors
Kentucky
$1.03M +$203K +19,900 +25%
TCIM
41
TIAA CREF Investment Management
New York
$1.01M -$167K -16,380 -14%
Deutsche Bank
42
Deutsche Bank
Germany
$948K -$1.85M -181,554 -67%
GAM
43
Gotham Asset Management
New York
$903K -$1.37M -133,949 -61%
MCC
44
Malaga Cove Capital
California
$882K -$285 -28 -0%
TC
45
TFS Capital
Pennsylvania
$879K +$853K +83,694 New
Royal Bank of Canada
46
Royal Bank of Canada
Ontario, Canada
$856K -$170K -16,669 -17%
Wellington Management Group
47
Wellington Management Group
Massachusetts
$828K
GC
48
Guggenheim Capital
Illinois
$795K -$72.3K -7,097 -9%
AIMCA
49
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$753K
TA
50
Teachers Advisors
New York
$719K +$19.9K +1,953 +3%

SCMP Hedge Fund Activity: Q2 2017 in Review

167 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Sucampo Pharmaceuticals, Inc. (SCMP) for Q2 2017, worth a combined $272M — down 5.2% from $287M a quarter earlier.

Fund positioning in SCMP was balanced in Q2 2017: 23 funds opened new positions, 23 closed out, 68 added to existing stakes and 46 trimmed.

The largest buyer was NEA Management Company, opening a new position worth an estimated $12.8M. The largest seller was Redwood Investments, exiting entirely with an estimated $6.63M sold.

  • 167 institutional investors held Sucampo Pharmaceuticals, Inc. (SCMP) as of Q2 2017, unchanged from Q1 2017.
  • Funds reported $272M of Sucampo Pharmaceuticals, Inc. stock for Q2 2017, down 5.2% quarter-over-quarter.
  • 23 funds opened new Sucampo Pharmaceuticals, Inc. positions in Q2 2017 and 23 closed out, a net change of 0 holders.
  • The largest Sucampo Pharmaceuticals, Inc. buyer in Q2 2017 was NEA Management Company, an estimated $12.8M added.
  • The largest Sucampo Pharmaceuticals, Inc. seller in Q2 2017 was Redwood Investments, an estimated $6.63M sold.

Based on aggregated 13F filings for Q2 2017.